D-0375-2025 Class II Ongoing
FDA drug recall D-0375-2025 was initiated by Apipharma on Apr 9, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 4,218 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 30, 2025
- Initiation Date
- Apr 9, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,218 boxes
Product description
Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ UPC 3 858882 103534 and UPC 3 858882 101318
Reason for recall
CGMP Deviations
Distribution pattern
AZ
Code information
Lot #: A00001, Exp.: 2027-12; A00005, Exp.: 2027-01; B00001, Exp.:2028-02
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0375-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026